Skip to content
onsuggest
Log in
Article en

Eating disorders are on the rise. GLP-1s could make things worse.

Source: MIT Technology Review ·

GLP-1 weight-loss drugs are one of the biggest biotech breakthroughs of the last decade. But to some clinical psychologists, they can represent something more sinister—a potential trigger for eating disorders. A new report suggests that the global incidence of anorexia nervosa and bulimia nervosa shot up between 1990 and 2023—by a whopping 71%. By 2023,…

Open the original Discover more

1 people saw it

Keyboard shortcuts

Previous discovery
←P
Next discovery
→N
Like
L
Not for me
X
Save
S
Show this help
?
Close
Esc

Shortcuts work on the discovery page.